6 October 2022

Case study Polymyalgia Rheumatica Scleroderma

One size does not fit all

6 October 2022

Polymyalgia Rheumatica Reactive Arthritis Research Sex

Sex and gender in rheumatology: Summit roundup

29 September 2022

Reactive Arthritis Research

Encouraging results from early lupus drug trial

29 September 2022

Dermatology Reactive Arthritis

Confirmation of PPI and lupus link

29 September 2022

Gout Spondyloarthritis

No heart attack, no worries?

21 September 2022

Fibromyalgia Mental Health Pharmaceuticals TGA

Paracetamol limits flagged as self-harming rises

21 September 2022

Biologics Reactive Arthritis

Reducing risk of HCQ retinopathy comes at a cost

20 September 2022

Reactive Arthritis Research

CAR T-cell therapy shows promise in lupus

15 September 2022

Fibromyalgia Osteoarthritis Research

Vitamin B12 may help fibromyalgia symptoms

8 September 2022

Vasculitis

Rheumatology’s unspoken cardiac risk

1 September 2022

COVID-19 Reactive Arthritis

The lupus pain in Spain stays mainly when over target again

1 September 2022 SPONSORED

Osteoarthritis

Fibromyalgia in patients with axial spondyloarthritis

1 September 2022

Biologics Spondyloarthritis

Triple therapy: the patients’ perspective

25 August 2022

cardiovascular Conditions Scleroderma

Promising secukinumab results in children

22 August 2022

PBS Reactive Arthritis

Anifrolumab hits PBAC roadblock

18 August 2022 SPONSORED

giant cell arteritis

A synthesis of emerging evidence in inflammatory arthritis